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The Myosin Start-of-Power Stroke State and How Actin Binding Drives
the Power Stroke
Matthias Preller1, Kenneth C. Holmes2.
1Hannover Medical School, Hannover, Germany, 2Max Planck Institute for
Medical Research, Heidelberg, Germany.
We propose that on binding to actin at the start of the power stroke the myosin
cross-bridge takes on the rigor configuration at the actin interface. Starting from
the pre-power stroke state, this can be achieved by a small movement (16 rota-
tion) of the lower 50K domain without twisting the central b-sheet or opening
switch-1 or switch-2. The movement of the lower 50K domain puts a strain on
the W-helix. This strain tries to twist the b-sheet, which could drive the power
stroke. This would provide a coupling between actin binding and the execution
of the power stroke. During the power stroke the b-sheet twists, moving the P-
loop away from switch-2, which opens the nucleotide binding pocket and sep-
arates ADP from Pi. The power stroke is different from the recovery stroke
because the upper and lower 50K domains are tethered in the rigor
configuration.
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The Myosin Inhibitor Blebbistatin Stabilizes the Super-Relaxed State in
Skeletal Muscle
Clyde Wilson1, Nariman Naber1, Edward Pate2, Roger Cooke1.
1Biochem/Biophys, Univ California, San Francisco, CA, USA,
2Bioengineering, Washington State University, Pullman, WA, USA.
The super-relaxed state of myosin (SRX) in which the myosin ATPase activity
is strongly inhibited has been observed in a variety of muscle types. It has been
proposed that myosin heads in this state are inhibited by binding to the core of
the thick filament in a structure known as the "interacting-heads motif". The
myosin inhibitor blebbistatin has been shown in structural studies to stabilize
the interacting-heads motif. Here we have utilized measurements of single
ATP turnovers to show that blebbistatin also stabilizes the SRX in both fast
and slow skeletal muscle. We find that blebbistatin is more effective in stabi-
lizing the SRX in slow skeletal fibers than in fast skeletal fibers. In the absence
of blebbistatin, the SRX is destabilized if the myosin heads are not relaxed, e.g.
rigor, rigor-ADP or activated. In the presence of blebbistatin the SRX is stable
even in these conditions. A similar stability of the SRX is seen in tarantula fi-
bers in the absence of blebbistatin. We show that spin-labeled nucleotides have
an oriented spectrum in the SRX in slow skeletal muscle in the presence of
blebbestatin that is similar to that observed in relaxed tarantula fibers in the
absence of blebbistatin. This observation shows that the structure of the SRX
is similar in different muscle types and in the presence and absence of blebbis-
tatin. The conformation of the nucleotide site in the SRX is closed, with a
conformation similar to that seen in other myosin nucleotide states as measured
by the mobility of spin probes bound at the active site.
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Attached Molecular Motor in Trapped Single Molecule Assay as a
Bi-Dimensional Brownian Multi-Stable System
Lorenzo Marcucci, Toshio Yanagida.
Osaka University, Suita (Osaka), Japan.
To elucidate the physical properties of the force generation mechanism in mo-
lecular motors, we have obtained an analytical solution of the bi-dimensional
Fokker-Plank equation which describes a common setup used in single mole-
cule experiments. As a first application of this general result, we have shown
that the size of the trapping system affects the dwell time of a multi-stable
particle linearly. A quantitative application to skeletal actomyosin complex,
using direct observation of force generation
dynamics in the literature, shows that the
size of the trapping system used was impor-
tant for increasing the dwell time of the
myosin head stable states to an observable
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Direct Observation of Phosphate Inhibiting the Force-Generating Capac-
ity of a Mini-Ensemble of Myosin Molecules
Sam Walcott1, Matthew Turner2, Mike Woodward2, Edward P. Debold2.
1Mathematics, University of California, Davis, CA, USA, 2Kinesiology,
University of Massahcusetts, Amherst, MA, USA.
Elevated levels of phosphate (Pi) reduce isometric force, providing support
for the notion that the release of Pi from myosin is closely associated withthe generation of muscular force. Pi is thought to rebind to actomyosin in an
ADP-bound state and reverse the force-generating steps, including the rotation
of the lever arm (i.e. the powerstroke). Despite extensive study this mechanism
remains controversial in part because it fails to explain the effects of Pi on
isometric ATPase and unloaded shortening velocity. To gain new insight into
this process, we determined the effect of Pi on the force-generating capacity
of a small ensemble of myosin (~12 myosin heads) using a three-bead laser
trap assay. In the absence of Pi, myosin pulled the actin filament an average dis-
tance of 545 4nm, translating into an average peak force of 1.2pN. By contrast
in the presence of 30mM Pi, myosin displaced the actin filament by only 135
1nm, generating just 0.2pN of force. The elevated Pi also caused a>65% reduc-
tion in binding event lifetime, suggesting that Pi induces premature detachment
from a strongly-bound state. Definitive evidence of a Pi-induced powerstroke
reversal was not observed therefore we determined if a branched kinetic model
in which Pi induces detachment from a strongly-bound, post-powerstroke state
could explain these observations. The model was not only able to accurately
reproduce the present data but it was also able to reproduce the effect of Pi
on both isometric ATPase in muscle fibers and actin filament velocity in a
motility assay. The ability of the model to capture the present as well as pre-
vious findings suggests that Pi-induced inhibition of force may proceed along
a different kinetic pathway from force-generation.
794-Pos Board B549
Understanding the Effects of Cardiomyopathy Causing Mutations on
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Masataka Kawana, Carol Cho, Rebecca Taylor, Chao Liu, Shirley Sutton,
Kathleen Ruppel, James Spudich.
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Cardiomyopathy is one of the leading causes of sudden cardiac death across the
developed world. Over the last twenty years numerous single point mutations in
the cardiac contractile apparatus have been implicated in hypertrophic and
dilated cardiomyopathy (HCM or DCM), out of which nearly 40% of them
are housed in the human b-cardiac myosin. Nonetheless, the underlying molec-
ular effects of most of these mutations remain elusive. The cardiac muscle
cyclically contracts under varying loads and it is likely that the mutations in
the b-cardiac myosin affect the power output of the heart. We hypothesize
that these mutations cause a fundamental mechanistic change in the power
output of the cardiac myosin contractile system by either altering force or ve-
locity of contraction, which ultimately compromises heart function and results
in the clinical phenotypes.
Using a combination of biochemistry and single molecule spectroscopy we
show that two HCM-causing mutations (R403Q and R453C) in a truncated
version of human b-cardiac myosin ending after the essential light chain (1-
808) cause an increase in the power output by two different mechanisms. For
R403Q we see a ~20% increase in the maximum unloaded velocity, whereas
for R453C the major change is a ~50% increase in the intrinsic force generated
by a single myosin head. On the other hand, with the DCM-causing S532P b-
cardiac myosin mutant both unloaded velocity and intrinsic force is decreased
as compared to the wild type, predicting a lower power output. These results
indicate that distinct molecular mechanisms for altering power output are oper-
ative for different cardiomyopathy-causing mutants. Work is currently being
performed to understand these and other cardiomyopathy-causing mutations
using an extended version of the human b-cardiac myosin molecule (1-843)
with both human light chains.
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Optical Trapping Shows a 3-Fold Increase in Myosin Head Stiffness by the
FHC-Mutation R723G in the b-Cardiac Myosin Heavy Chain
Christoph Werkman1, Nils Hahn1, Antonio Francino2,
Francesc Navarro-Lope´z2, Theresia Kraft1, Walter Steffen1,
Bernhard Brenner1.
1Molecular and Cell Physiology, Hannover Medical School, Hannover,
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Missense mutations in the b-cardiac myosin heavy chain (b-MyHC) are the
most frequent cause of Familial Hypertrophic Cardiomyopathy (FHC). For
these mutations mutant and wildtype b-MyHC are co-incorporated in the
contractile apparatus, and direct functional effects of such mutations presum-
ably trigger development of the FHC-phenotype. In M. soleus biopsies of
affected patients we previously found increased isometric force generation
for the converter mutation R723G, most likely due to increased stiffness of
the myosin head domain. Quantification of the increase in head stiffness
from fiber studies, however, was complicated by filament compliance, as
well as non-equal and variable co-expression of mutant and wildtype protein
in the tissue samples.
